ABSTRACT
Cesium-137 gamma irradiators have been commonly used in hospitals and
research facilities for more than 70 years. Although they remain effective, the U.S.
government is currently providing incentives for facilities to replace Cesium irradiators
with x-ray irradiators. This is being done to minimize bioterrorism risk and maximize the
security of isotope-based radiation. Although there is significant information in the
literature regarding the potential differences in gamma and x-ray radiation, at the same
dose levels, some differences remain poorly characterized.
In this study MC38 (murine colon adenocarcinoma) and B16F10 (murine
melanoma) cellular responses to equivalent gamma and x-ray radiation doses were
examined. Colony forming assays were performed and survival fractions compared. The
results indicate MC38 cells are more sensitive to radiation than B16F10 cells.
Additionally, MC38 cells are more susceptible to gamma radiation than x-ray radiation at
any given dose, whereas the opposite is true for B16F10 cells. Thus, there were
potentially important comparative differences (gamma vs x-ray) in cell survival. Western
blot protein analysis and NanoString mRNA analysis were completed for gamma
radiation of B16F10 cells to examine the mechanisms of cell death. Changes in protein
and mRNA expression were mainly relatively small. Importantly, for research purposes,
it appears genes associated with the apoptosis pathway will increase similarly, with dose,
for both types of radiation.
Due to the COVID-19 pandemic, this research could not be completed as planned
on the Dartmouth campus. The project required the physical irradiation of cancer cells.
Without access to the Dartmouth irradiators, approximately one half of the planned
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experiments could not be completed. Therefore, some data was calculated using
previously existing information. The studies will be completed by returning laboratory
personnel.
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1. INTRODUCTION
1.1 Background
In the Energy Policy Act of 2005 (section 651), the U.S. Congress requested the
U.S. Nuclear Regulatory Commission (NRC) “submit to Congress the results of a study
by the National Academy of Sciences about industrial, research, and commercial uses for
radiation sources” and establish “the Task Force on Radiation Source Protection and
Security to evaluate and report to Congress and the President on the security of radiation
sources in the United States from potential terrorist threats, sabotage, theft, or use of a
radiation source in a radiological dispersal device” [1]. The 2008 report by the
Committee on Radiation Source Use and Replacement examined Category 1 and 2
radioactive sources and determined that over 99% of high security risk radioactive
sources in the U.S. are americium-241, cesium-137, cobalt-60, and iridium-192 sources.
The greatest threat is posed by cesium-137 in cesium chloride (CsCl) sources due to its
prevalence in high population density areas and its solubility and dispersibility as a
pressed powder [2].
The committee recommended replacement of CsCl sources by discontinuing
licensing of new CsCl irradiator sources, implementing incentives to decommission
sources already in use, and prohibiting the export of these sources except for disposal at a
licensed facility [2]. The committee recommended x-ray irradiators as a replacement for
the current cesium irradiators [2]. To aid in the disposal of these cesium sources, the U.S.
Department of Energy’s National Nuclear Security Administration began the Cesium
Irradiator Replacement Project (CIRP) in 2015. CIRP incentivizes replacement of cesium
irradiators with x-ray irradiators by fully funding the removal and disposal of the cesium
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irradiator using the government’s Off-Site Source Recovery Project and reimbursing
about half of the price of the x-ray irradiator [3]. At an estimated rate of 70 irradiators a
year, the CIRP projects disposal of all high activity cesium sources will be complete by
2027 [3].
In commenting on the 2008 report by the Committee on Radiation Source Use
and Replacement, the Advisory Committee on the Medical Use of Isotopes (ACMUI)
reported concern about the recommendation to replace cesium irradiators with x-ray
irradiators given the efficacy of such alternatives was not established [4]. Little research
has been undertaken to examine significant differences between gamma irradiation
provided by Cs-137 sources and x-ray irradiators, and characterization of the differences
between irradiator types is incomplete. Pacific Northwest National Laboratory, who is
aiding the Defense Nuclear Nonproliferation Office of Radiological Security to
implement the CIRP project, is funding research at institutions exchanging cesium
irradiators for x-ray irradiators (or other alternatives) in order to better understand the
transition process and changes in irradiation protocols required by the transition to a new
technology [5].
Irradiators are used for a wide variety of clinical and research applications
including, but not limited to, irradiating blood to prevent transfusion-associated graftversus-host disease, irradiating mice for research in bone-marrow transplant studies, and
irradiating cells or animals for cancer treatment [6]–[8]. Several factors contribute to
cellular responses induced by radiation. There are many factors that affect the ability of
radiation to induce cell death, including the radiation dose, the dose rate, and the cell
type[9]. Classically, radiation is delivered in a fractionated form, with multiple treatments
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of a dose given over several days or weeks, such as 30 doses of 2 Gy (30 x 2 Gy), or 3
doses of 8 Gy (3 x 8 Gy). These fractionation schemes also factor into radiation’s ability
to induce cell death. These factors can lead to biological differences, depending on the
cell type, altering the overall effectiveness of a given dose. The variation in radiations
effectiveness across cell types is known as the relative biological effectiveness (RBE)
[10], [11].
Ionizing radiation is used as a cancer therapy to induce cell death and prevent
proliferation within a tumor. The heightened proliferation of some cancers is thought to
rely on the suppression of apoptosis signals (programmed cell death) [6]. However,
radiation induced cell injury can trigger cell death mechanisms, including apoptosis.
Ionizing radiation can cause both direct and indirect damage; indirect damage occurs
through the formation of reactive oxygen species. These reactive oxygen species can
oxidize proteins and lipids as well as damaging DNA [12]. Radiation induced DNA
damage has been most closely studied and is considered the most important factor in cell
responses to radiation [13]. Cellular enzymes can metabolize reactive oxygen species to
minimize damage, including superoxide dismutases, peroxiredoxins, and glutathione
peroxidases [13]. However, sufficient damage can trigger apoptosis or other forms of cell
death.
Ionizing radiation induced DNA damage can involve alteration of the nucleotide
bases and sugars, cross-link formation, DNA clustering, and single and double stranded
breaks [13]. This DNA damage triggers a cell cycle checkpoint response. The checkpoint
response pauses the cell cycle, either allowing time to repair the DNA damage before
continuing, or initiating cell death pathways if there is great enough damage [13].
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Ionizing radiation can also target lipids and proteins. Lipids are damaged either directly
or, more frequently, indirectly. The interaction of reactive oxygen species with the lipid
bilayer causes lipid peroxidation, particularly of polyunsaturated fatty acids, which leads
to an increase in membrane permeability and thereby disrupts transmembrane processes
and ion gradients [13]. Proteins affected by ionizing radiation can be subjected to
reducing or oxidizing post-translational modifications which can alter the structure,
function, and regulation of the protein and its enzymatic activity. Protein modification,
due to the effect of ionizing radiation, results in pathway signaling changes and may
explain some of the cellular responses to ionizing radiation [13].
Some published studies indicate gamma and x-ray radiation are not exactly
equivalent at the same dose. Bone marrow transplant research in mice has suggested, in
this case, the RBE of x-rays is 20-30% higher than that of gamma radiation, meaning a
lower overall x-ray dose is required for the same effect [10]. In a study on blood
irradiation using gamma and x-ray radiation, small changes in red blood cell permeability
were observed. Additionally, there was a slight elevation of free plasma hemoglobin at 25
Gy x-ray radiation relative to gamma radiation and slight decrease of extracellular
potassium levels at 35 Gy for x-ray irradiation when compared to 35 Gy gamma
radiation. While it was concluded these differences were unlikely to be clinically
relevant, they nevertheless suggest cells may respond differently to gamma and x-ray
irradiation [7]. A study comparing the effect of 320 kV x-rays to Cs-137 gamma rays on
bone marrow and splenocyte cells in C.B-17 mice determined the x-rays were more
effective at destroying bone marrow cells and less effective destroying splenocytes than
the gamma rays [11]. Other studies examining bone marrow irradiation have also
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indicated differences in leukocyte, myeloid, and B cell reconstitution. Specifically, x-rays
radiation resulted in less reconstitution of leukocytes and B cells but increased myeloid
reconstitution. Additionally, there was reduced survival of mice after x-ray radiation due
to a lack of CD45 as a result of bone marrow depletion [14]. Additional studies have
indicated the two radiation methods are functionally equivalent at the same dose for
insect sterilization, mitotic inactivation of mouse embryonic fibroblasts, and fibroblast
survival in vitro and thus require no change in protocol [14]. The differing biological
effects of gamma and x-ray irradiation highlighted by these previous studies indicate a
cell type dependent, complex relationship between type of irradiation and survival rate.

1.2 Thesis Purpose
The purpose of this project is to examine differences in the effects of gamma and
x-ray irradiation in accordance with the PNNL statement of work. Several methods are
used in combination to better understand the effects of each radiation dose on the cancer
cells. In vitro comparison of the survival fraction provides information about relative cell
kill at each dose. Examination of protein and RNA expression after radiation treatment
provides further insight into the mechanisms of cell death and repair occurring as a result.
Studying the ways in which the survival fraction, protein expression, and RNA
expression differ provides insights into the ways gamma and x-ray irradiation of cells
differ. By extension, this research provides insight into how the process of transferring
from cesium-137 irradiators to x-ray irradiators will require changes to research and
treatment protocols.
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2. MATERIALS AND METHODS
2.1 Cell Culture
Two cancer cell lines were used for the in vitro radiation studies, B16F10
(murine melanoma) and MC38 (murine colon adenocarcinoma). B16F10 cells were
obtained from the American Type Culture Collection (ATCC) (Manassas, VA), and
MC38 cells were obtained from Professor Sentman’s Lab at Dartmouth.
B16 cells were cultured in RPMI (Mediatech, Inc., Manassas, VA) with 10% fetal
bovine serum (HyClone Laboratories, Inc., Logan, UT) and 1% of a penicillinstreptomycin solution (10,000 units/mL penicillin and 10,000 µg/mL streptomycin,
HyClone Laboratories, Inc., Logan, UT). Cells were plated at a density of 1.25 x 105
cells/mL on standard tissue culture dishes and incubated at 37ºC and 5% CO 2.
MC38 cells were cultured in DMEM high (Mediatech, Inc., Manassas, VA) with
10% fetal bovine serum (HyClone Laboratories, Inc., Logan, UT) and 1% of a penicillinstreptomycin solution (10,000 units/mL penicillin and 10,000 µg/mL streptomycin,
HyClone Laboratories, Inc., Logan, UT). Cells were plated at a density of 1.5 x 106
cells/mL on standard tissue culture dishes and incubated at 37ºC and 5% CO 2.

2.2 Irradiators
Delivery of two different radiation types, gamma rays and x-rays, required
different types of irradiators. Gamma rays were generated from an 8,000 Curie JL
Shepard Cesium-137 irradiator. Cesium gamma rays have an energy of 662 keV. X-rays
were delivered from a 320 kV irradiator (XRAD 320) manufactured by Precision X-Ray,
North Branford, CT. The dose rate for both types of radiation was 10 Gy per minute.
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2.3 Assessment of Plating Efficiency
Cells were plated at a density of 100 cells per cell culture plate. The number of
cells attached to the plate were counted the following day. Plating efficiency was
calculated as the percent of cells that attached relative to the number of cells plated.

2.4 Colony Forming Assays
Cells were plated at a density of 100 cells/well in a 12-well cell culture plate.
Twenty-four hours later cells received 0 Gy, 0.5 Gy, 1 Gy, 2 Gy, 4 Gy, 6 Gy, 8 Gy, or 10
Gy. Culture media was changed four days following irradiation. Eight days following
irradiation, cells were fixed using 100% ethanol at room temperature for 10 minutes.
Cells were then stained for 10 minutes with Methylene Blue (Sigma Aldrich, St. Louis,
MO). Quantifiable colonies contained at least 50 cells. Colonies were counted, and the
total number of colonies from each experimental group were compared to an unirradiated
control to determine percent survival for each radiation dose.

2.5 RNA Analysis
The day prior to irradiation, cells were plated at a density of 150,000 cells/well.
Cells then received 0 Gy, 2 Gy, 6 Gy, or 18 Gy. Twenty-four hours post irradiation, cells
were lysed, and the RNA purified. Purification of RNA was carried out using, and in
accordance with, the instructions for the Qiagen RNeasy Mini Kit (Qiagen, Venlo,
Netherlands). A GeneQuant II spectrophotometer from Pharmacia Biotech (Piscataway,
NJ) was used to establish the amount and purity of RNA in order to normalize the amount
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of RNA across samples. For each sample, 50ng of RNA were used for NanoString RNA
expression quantification and analysis. Over 700 genes were analyzed using the
NanoString PanCancer Pathways Panel (murine). Quantification of expression levels was
completed using the NanoString nCounter Analysis System (NanoString Technologies,
Seattle, WA) according to their instructions. The samples were normalized with respect
to the expression of housekeeping genes. The normalization factor was determined with
the geometric mean. Samples with fewer than 20 mRNA counts were not included in the
analysis. The nSolver Analysis (v. 4.0) and Advanced Analysis Software were used to
examine the collected data.

2.6 Protein Analysis
Cells were plated at a density of 150,000 cells/well the day prior to irradiation.
The experimental groups received 0 Gy, 2 Gy, 8 Gy, or 18 Gy. Twenty-four hours
following irradiation, cells were lysed using a lysate buffer. The lysate buffer consists of
10ml of 40mM Hepes buffer, a complete mini tablet, and 100µl of orthovanadate. Cell
lysate was then stored at -20ºC. In order to normalize the protein concentration across
samples a Bradford assay was used. Prepared, normalized samples were stored at -20ºC.
A traditional Western blot protocol using SDS-PAGE was used. Briefly, 12%
polyacrylamide gels were used to separate proteins (run at 85V). Proteins were then
transferred to a nitrocellulose membrane (run at 70V for 90 minutes in cold water). The
membrane was incubated with the blocking solution (bovine serum albumin (BSA) with
Tris-Buffer Saline/Tweet (TBST)) for 30 minutes. The membrane was then incubated
with primary antibody for at least 12 hours at 4ºC. The membrane was subsequently
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thoroughly washed in TBST before being incubated at room temperature with secondary
antibodies conjugated with horseradish peroxidase for one hour. Visualization of the
proteins was achieved with enhanced chemiluminescence in a G:Box Syngene (from
New England Biogroup, Atkinson, NH). Protein expression was quantified through
densitometry analysis in ImageJ and normalized with respect to the expression of -actin,
the chosen loading control.

3. RESULTS
3.1 Survival Fractions
Our results, using of the colony forming assay, suggest that the same dose of
gamma and x-radiation demonstrate similar, but not identical cytotoxicity profiles in two
different murine cancer cell lines. Overall, the colon cancer cells (MC38) were more
radiosensitive that the melanoma cells (B16) for both gamma rays and x-rays. With
respect to radiosensitivity and radiation type, MC38 cells were more sensitive to gamma
irradiation while B16F10 cells were more sensitive to x-rays, at all doses used (Figure 1).
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Figure 1: Surviving fractions relative to a control of untreated cells as a function of dose, type of irradiation, and
cell type based on colony forming assays. MC38 cells are more susceptible to gamma radiation while B16F10 cells are
more susceptible to x-ray radiation at any dose. This figure was created using data collected in the laboratory and
extrapolating based on the data provided in a study by Scott et al [11].

3.2 Genetic Expression
The genetic expression of irradiated cells was only conducted in the B16F10 cell
line using Cesium gamma irradiation, twenty-four hours following irradiation. The most
significant changes in genetic expression (mRNA expression) following irradiation,
relative to control, were in genes associated with cell cycle and transcriptional
misregulation pathways. Although we expected the genes associated with apoptosis to
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change in a dose dependent manner relative to control, we saw minimal change at any
dose (Figure 2).

Figure 2: Overview of differences in mRNA expression of B16F10 cells 24 hours post gamma irradiation relative to
untreated cells. Transcriptional Misregulation in Cancer genes including Cdkn1a (p21), a cell cycle regulatory gene,
and AKT1, a pro-survival gene, show the greatest dose dependent response in expression. Apoptotic genes (eg. proapoptotic genes Tnfrsf10b, Bax, and Caspase 3 and anti-apoptotic genes BCL2 and AKT1) show relatively little change
in expression as a function of the gamma dose administered.

The most differentially expressed gene at all radiation doses, relative to control,
was Cdkn1a. Cdkn1a, also known as p21, is a cell cycle regulatory gene that is in the
transcriptional misregulation pathway [15]. Its mRNA expression increased with
increasing dose (Figure 3). The expression of p27, a key regulator of cell proliferation,
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was decreased slightly relative to control at all radiation doses [16]. GSK3, a regulator
gene associated glycogen metabolism and protein translation for cell cycle regulation,
cell proliferation and apoptosis, showed essentially no change relative to control at 2 Gy
but increased slightly relative to control with increasing radiation dose, 6 and 18 Gy [17],
[18].
TNFrsf10b expression, associated with intracellular based cytotoxicity, increased
at all radiation doses relative to control and had the most significant expression difference
of any apoptotic gene at any dose examined [19]. Bax, a pro-apoptotic regulator [20],
mRNA expression increased significantly relative to control at all doses with increased
expression as the radiation dose increased. Caspase 3 is an apoptotic protein promoting
DNA fragmentation and reducing immunogenicity of cell death [6], [20]–[22]. Caspase 3
mRNA expression decreased significantly (a log2 fold decrease of 0.24) at a low dose of
radiation (2 Gy). As the radiation dose increased, genetic expression of caspase 3
increased back to unirradiated levels. BCL2 and mTOR, both pro-survival apoptotic
regulators, showed almost no difference in genetic expression relative to control at any
dose [6], [20]–[24].
Akt1 expression, associated with increased survival, decreased slightly with
increasing radiation dose [6], [12], [17], [23], [25]. At a dose of 18 Gy, Mdm2, involved
in the inhibition of p53 and associated with increased survival, mRNA expression
exceeded a 1.5-fold change relative to control [24], [26]. Mdm2 expression increased
with increasing radiation dose. HSP70 mRNA, an apoptotic inhibitor involved in
immunogenic cell death, showed little change relative to control at 2 Gy but its
expression increased slightly with increasing dosage [20]–[22], [27]. ERK1/2 (MAPK3
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and MAPK1) genetic expression, involved in immunogenic cell death, remained at the
same level as control over the range of 2-18 Gy doses [21], [24]. A more comprehensive
summary of the functional changes associated with the expression of the genes discussed
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Figure 3: Linear fold change of mRNA expression 24 hours post gamma radiation treatment of B16F10 cells relative
to untreated control cells. Most genes show relatively little change in expression relative to control. However,
Cdkn1a (p21), a cell cycle regulatory gene, Tnfrsf10b, which encodes a death receptor involved in extrinsic apoptosis,
and Mdm2 (at 18 Gy), a pro-survival p53 inhibitor, exceed a 1.5-fold change in expression relative to control.

Figure 4 is a volcano plot that demonstrates the difference in mRNA expression
of individual genes 24 hours after receiving 18 Gy. All genes examined are shown in grey
except those involved in apoptosis, which are shown in yellow. The y-axis represents
statistical significance with more significant differences in expression at the top. The
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relative difference in gene expression, at that dose, relative to control is measured on the
x-axis with larger differences toward the lateral edges of the plot. For apoptotic genes,
only changes in expression of TNFrsf10b and Bax at 18 Gy were statistically significant
at an adjusted p-value of 0.05. The change in expression of AKT1, at 18 Gy, was
statistically significant at an adjusted p-value of 0.10.

Figure 4: Volcano plot indicating changes in mRNA expression of apoptosis regulatory genes 24 hours after
receiving 18 Gy of gamma radiation relative to untreated control cells. Apoptosis genes are shown in yellow while
other genes tested are in grey. The amount by which expression levels changed is indicated on the x-axis: larger
changes in expression fall to the lateral edges. The statistical significance of the change in expression is shown on the
y-axis with more statistically significant differences toward the top of the figure. The apoptosis genes with the most
statistically significant (with an adjusted p value of less than 0.05) change in genetic expression relative to control at a
dose of 18 Gy are Tnfrsf10b, which is pro-apoptotic, Bax, also a pro-apoptotic gene, and Akt1, a pro-survival gene.
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Table 1: Summary of gene function and observed changes in expression

Gene

Pathways(s) and Function
Required for p53-mediated repression of
transcription
Encodes protein death receptor 5, extrinsic
apoptosis, anti-survival

Cdkn1a (p21)
Tnfrsf10b

Change in
Expression
Large
increase
Increase

Bax

anti-survival, promotes cytochrome c release,
intrinsic apoptosis

Increase

Caspase 3

apoptosis, lysosome dependent cell death, leads to
DNA fragmentation and reduces immunogenicity

Slight
decrease

autophagy, apoptosis, pro-survival

Steady

autophagy, apoptosis, metabolism, pro-survival

Decrease

mTOR
AKT1 (Protein
Kinase B)
BCL2
p-MDM2
p27
HSP70
p-ERK1 (MAPK3)
p-ERK 2 (MAPK1)

intrinsic apoptosis, lysosome-dependent cell death,
senesence, inhibits cytochrome c release (prosurvival)
cell cycle, p53 inhibitor, pro-survival
cell cycle arrest
apoptosis inhibitor, promotes phagocytosis by
dendritic cells (immunogenic cell death)
immunogenic cell death
pro-survival in apoptosis, promotes immunogenic
cell death

p-GSK3

metabolism, promotes glycogen synthesis

Steady
Increase
Steady
Slight
increase
Steady
Steady
Slight
increase

3.3 Protein Expression
The data presented in this section was collected from gamma irradiation of
B16F10 cells. Several proteins involved in regulation of cell survival and death were
examined. Table 2 provides a summary of the proteins and the changes in their
expression.
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Figure 5: Western blot protein expression levels of B16F10 cells 24 hours post gamma irradiation. The proteins
shown are involved in metabolic activity regulation (p-GSK3), cell cycle regulation (p27), pro-survival proteins (pmTOR, p-AKT 473 also known as protein kinase B, BCL2, survivin, and p-MDM2), pro-apoptotic proteins (cleaved
PARP-1 and the inactive pro-caspase 3 as well as the active form cleaved caspase 3), and pro-immunogenic cell death
proteins (HSP70, p-ERK1 also known as MAPK3, p-ERK2 also known as MAPK1, and calreticulin). B-actin was chosen to
be the loading control. Surprisingly, cleaved caspase 3 shows little protein expression at any dose.

The translation of genetic expression to protein production does not always track
as closely as one might predict. For irradiation of cells the challenges include dose, cells
type and assay timing. In our study protein changes that tracked with genetic changes
included: an increase p-GSK3, a metabolic protein promoting glycogen synthesis,
expression at 2 Gy, but no change relative to control after 8 or 18 Gy exposure [17], [18].
The relative amount of p27, promoting cell cycle arrest, increased relative to control at
radiation doses of 2 and 8 Gy and reduced levels relative to control at 18 Gy [16].
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Figure 6: Linear fold change of protein expression relative to control and normalized relative to -actin in B16F10
cells 24 hours post gamma irradiation. Protein expression showed more change in expression relative to control than
the mRNA. Proteins that exceed a 1.5- or 0.66-fold change are pro-apoptotic protein cleaved caspase 3,pro-survival
proteins p-mTOR, p-AKT 473 (Protein Kinase B), BCL2, and p-MDM2, cell cycle regulatory protein p27, and proimmunogenic cell death proteins HSP70, p-ERK2 (MAPK1), and calreticulin.

Cleaved PARP-1 expression, involved in apoptosis and DNA damage repair, had
little change relative to control at a 2 Gy dose but increased at 8 Gy and dropped slightly
from its 8 Gy expression level at a dose of 18 Gy [6], [21], [28], [29]. Pro-caspase 3 (the
inactive form of caspase 3) protein expression decreased slightly relative to control at 2
Gy and 8 Gy doses and returned to the same levels as control at 18 Gy. Cleaved caspase 3
is a pro-apoptotic protein promoting DNA fragmentation and reducing immunogenicity
of cell death [6], [20]–[22]. Contrary to expectation, the cleaved caspase 3 bands from the
western blot did not show much expression (see Figure 5). It is possible an error occurred
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in the process of cutting the membrane or staining with the antibodies. Thus, the data for
cleaved caspase 3 is potentially unreliable, although it is possible there was simply not
very much cleaved caspase 3 expression. However, the data collected suggests a slight
increase in expression at 2 Gy and 18 Gy with a larger increase at 6 Gy.
p-AKT 473 expression, a pro-survival protein also known as protein kinase B,
increased with increasing radiation dose and passes a 1.5-fold change threshold at 6 Gy
[6], [12], [17], [23], [25]. p-mTOR expression, pro-survival and anti-apoptotic, decreased
with increasing dosage with an initial fold change greater than 1.5 at 2 Gy and returning
to baseline by 18 Gy doses [22]–[24]. BCL2 is involved in intrinsic apoptosis [6], [20],
[21]. BCL2 expression levels were elevated above 1.5-fold change in expression at 2 Gy,
a decrease to roughly pre-radiation expression levels at 6 Gy and show reduced
expression (below a 0.66-fold change) at 18 Gy. The pro-survival protein survivin
expression shows an increase at 2 Gy and a slight decrease relative to control at 8 and 18
Gy [6], [27]. p-MDM2, a pro-survival p53 inhibitor, shows increased expression of
roughly 1.5-fold relative to control at 2 Gy and demonstrates a slight decrease in
expression with continuing increase in radiation dosage [24], [26].
Although the genetic expression was significant, following irradiation, for the
thermal regulatory and immunostimulatory gene HSP70, protein expression was minimal
except at 8 Gy [20]–[22], [27]. p-ERK1, also known as MAPK3 and involved in
immunogenic cell death, expression remained at roughly the same level as the control at
all doses [21]. p-ERK2, also known as MAPK1, an anti-apoptotic and pro-immunogenic
cell death protein, expression was decreased relative to control at all doses and below
0.66-fold change at 2 and 8 Gy [21], [24]. Somewhat disappointingly, the potent
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immunostimulatory protein calreticulin showed little expression change at all radiation
doses [6], [21], [22].
Table 2: Summary of protein function and observed changes in expression

Protein

Pathways(s) and Function

Change in Expression

Cleaved PARP-1

DNA damage repair, apoptosis,
parthanatos, product of caspase 3 or 7

Increase at 8 Gy, slight
decrease by 18 Gy

Pro caspase 3

inactive form of caspase 3

Slight initial decrease, return to
normal levels at 18 Gy

Cleaved caspase 3

apoptosis, lysosome dependent cell
death, leads to DNA fragmentation
and reduces immunogenicity

Increase, especially at 8 Gy

p-mTOR

autophagy, apoptosis, pro-survival

Initial increase and steady
decrease

p-AKT 473 (Protein
Kinase B)

autophagy, apoptosis, metabolism,
pro-survival

Increase

BCL2

intrinsic apoptosis, lysosomedependent cell death, senesence,
inhibits cytochrome c release (prosurvival)

Initial increase and steady
decrease

Survivin

pro-survival, inhibits apoptotic
proteins

Initial increase, quick return to
normal levels

p-MDM2

cell cycle, p53 inhibitor, pro-survival

Initial increase and steady
decrease

p27

cell cycle arrest

Increased at 2Gy and 8 Gy,
decreased at 18 Gy

HSP70

apoptosis inhibitor, promotes
phagocytosis by dendritic cells
(immunogenic cell death)

Decrease

p-ERK1 (MAPK3)
p-ERK 2 (MAPK1)

immunogenic cell death
pro-survival in apoptosis, promotes
immunogenic cell death

Steady
Decreased, steady

Calreticulin

immunogenic cell death, promotes
phagocytosis

Decreased, slight increase at 8
Gy

p-GSK3

metabolism, promotes glycogen
synthesis

Initial increase, quick return to
normal levels
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4. DISCUSSION
4.1 Survival Fractions
Overall this study demonstrates a relatively consistent and similar genetic,
proteomic and cytotoxic response in two murine cancer cell lines following gamma and
x-ray radiation, at the same dose. It was notable that B16F10 murine melanoma cells
were slightly more sensitive to x-rays than to gamma rays, at the same dose, meaning the
RBE of x-rays relative to gamma rays for B16F10 cells is less than 1. The MC38 murine
colon cancer cells were slightly more sensitive to gamma rays than x-rays, at the same
dose, meaning an RBE of greater than 1 for x-rays relative to gamma rays. For neither
cell line was the difference in RBE especially pronounced. This result is unsurprising
given that both techniques provide photons, though the energy of the photons differ (662
keV for gamma radiation and up to 320 keV for x-ray radiation). Moreover, this finding
is in agreement with the results of the study performed by Scott et. al. examining survival
at different doses in bone marrow and splenocytes of mice [11]. However, the results are
complicated by comparison with other studies; the functional differences between gamma
and x-ray radiation at a given dose have been shown in other publications to be
significant in some cases and insignificant in others [7], [10], [11], [14]. In order to
determine what factors contribute to the different responses of some cells to gamma and
x-ray radiation but not others at a given dose, further research examining the
characteristics of the cells affected versus cells unaffected is necessary. This information
could then be used to predict whether or not alterations to protocols written for cesium
irradiators are necessary when transferring to an x-ray irradiator.
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4.2 RNA (Genetic) and Protein Expression
mRNA and protein expression of B16F10 cells 24 hours after gamma irradiation
was examined in this study. The cell cycle regulatory gene cdkn1a (also known as p21)
showed increased mRNA expression relative to control. Cell cycle regulatory gene p27
generally showed little change in mRNA expression but showed increased protein
expression, especially at low radiation doses. The metabolic activity of the cells, as
measured via GSK3 expression, also likely increased as a result of radiation exposure.
The expression of the pro-apoptotic genes and proteins TNFRSF10b, BAX, cleaved
PARP-1, caspase 3, and mTOR generally showed increased expression, growing with
increasing dosage. This data suggests an increase in apoptotic cell death with increasing
doses of radiation treatment. However, apoptotic death potentially peaks at a dose lower
than 18 Gy as the protein expression showed a decrease in expression of pro-apoptotic
proteins at 18 Gy relative to the 8 Gy levels. Considered together, the expression of the
pro-survival, anti-apoptotic proteins (AKT, BCL2, Survivin, and p-MDM2) is increased
at low doses of radiation and decreases with increasing dosage as the cells sustain more
damage from ionizing radiation. The pro-immunogenic cell death proteins (HSP70, pERK1/2, and calreticulin) were generally decreased relative to control after treatment
with gamma radiation, though the mRNA expression was generally at the same level as
control at all doses.
Overall, most of the genes and proteins examined in this study showed little
change in expression relative to control at any dose. mRNA expression after gamma
irradiation showed the most effect on cell cycle regulatory genes, though expression of
genes regulating apoptosis also demonstrated a dose-related effect. Cdkn1a, a cell cycle
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regulatory gene associated with apoptosis, had the largest and most significant difference
in expression of any gene assessed. In general, gamma radiation resulted in limited
changes in the mRNA expression of apoptotic regulatory genes. The overall mRNA
expression trends show an increase in pro-survival and pro-apoptotic genes with
increasing radiation dose, and little or no change in genes linked to immunogenic cell
death. The protein expression changes, as examined by western blot analysis, show
slightly greater variation in expression than the mRNA, though the overall protein
expression changes of the apoptotic, immunogenic cell death, cell cycle, and pro-survival
proteins studied was also generally limited. The data demonstrates a slight increase of
pro-survival proteins especially at lower radiation doses, a slight increase in pro-apoptotic
and anti-apoptotic proteins at 2 Gy doses, a continuing increase in pro-apoptotic proteins
and a decrease in anti-apoptotic proteins at 6 Gy, and a decrease in both pro-apoptotic
and anti-apoptotic proteins at 18 Gy. These trends suggest apoptosis provides an
important role in preventing further tumor cell proliferation after receiving gamma
radiation, but apoptosis is not a sufficient explanation for the decrease in cell
proliferation.
It seems likely there will be slight differences in protein and mRNA expression
when using x-ray irradiation given that there was a difference in the survival fractions at
a given dose in this study, and with other blood irradiation and bone marrow studies
demonstrating slight differences [7], [11], [14]. Unfortunately, there is not enough
published information about these differences to determine if there will be a significant
effect without conducting a study such as the one outlined above.
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5. CONCLUSION
Although we demonstrated relative minor differences in the genetic, protein and
cytotoxic effects of x-ray and gamma ray irradiation, in two cancer cell lines, these
differences could prove clinically significant for higher doses and fractionated treatments.
Expansion of the experiments demonstrated in this thesis are an important next step in the
quest to understand and quantify the differences (and clinical relevance of those
differences) between the two types of irradiation. The methods and types of analysis
utilized provide a meaningful framework for future studies. Such in vitro experiments
will be very important for gamma and x-ray radiation dose conversions as gamma
irradiators are gradually eliminated from biomedical use worldwide. Accurate conversion
information is especially important for researchers with decades worth of gamma
radiation data who no longer have access to that radiation source. In vivo experiments
examining not only the mechanisms and pathways of cell death, but also tumor and
normal tissue responses, following x-ray and gamma ray irradiation will also be very
important.
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